Skip to Main Content

Author Details

Anna Gaulton
European Bioinformatics Institute (EMBL-EBI)
2002
51
27
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37933841The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods.Nucleic Acids Res2024
37933841The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods.Nucleic Acids Res2024
37069670Biomedical data analyses facilitated by open cheminformatics workflows.J Cheminform2023
37151295Illuminating the druggable genome through patent bioactivity data.PeerJ2023
37069670Biomedical data analyses facilitated by open cheminformatics workflows.J Cheminform2023
37151295Illuminating the druggable genome through patent bioactivity data.PeerJ2023
33983732Target-Based Evaluation of "Drug-Like" Properties and Ligand Efficiencies.J Med Chem2021
33837377Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.Nat Med2021
33507738Drug Safety Data Curation and Modeling in ChEMBL: Boxed Warnings and Withdrawn Drugs.Chem Res Toxicol2021
33983732Target-Based Evaluation of "Drug-Like" Properties and Ligand Efficiencies.J Med Chem2021
33507738Drug Safety Data Curation and Modeling in ChEMBL: Boxed Warnings and Withdrawn Drugs.Chem Res Toxicol2021
33837377Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.Nat Med2021
32645325The Global Phosphorylation Landscape of SARS-CoV-2 Infection.Cell2020
32645325The Global Phosphorylation Landscape of SARS-CoV-2 Infection.Cell2020
30398643ChEMBL: towards direct deposition of bioassay data.Nucleic Acids Res2019
31827124Improving the odds of drug development success through human genomics: modelling study.Sci Rep2019
33430932Reply to "Missed opportunities in large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery".J Cheminform2019
30398643ChEMBL: towards direct deposition of bioassay data.Nucleic Acids Res2019
30631996Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery.J Cheminform2019
31827124Improving the odds of drug development success through human genomics: modelling study.Sci Rep2019
33430932Reply to "Missed opportunities in large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery".J Cheminform2019
30631996Large scale comparison of QSAR and conformal prediction methods and their applications in drug discovery.J Cheminform2019
29567993Unexplored therapeutic opportunities in the human genome.Nat Rev Drug Discov2018
30351302A large-scale dataset of in vivo pharmacology assay results.Sci Data2018
29567993Unexplored therapeutic opportunities in the human genome.Nat Rev Drug Discov2018
29472638Unexplored therapeutic opportunities in the human genome.Nat Rev Drug Discov2018
30351302A large-scale dataset of in vivo pharmacology assay results.Sci Data2018
29472638Unexplored therapeutic opportunities in the human genome.Nat Rev Drug Discov2018
27899562The ChEMBL database in 2017.Nucleic Acids Res2017
28602100Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery.Expert Opin Drug Discov2017
28356508The druggable genome and support for target identification and validation in drug development.Sci Transl Med2017
27899665Open Targets: a platform for therapeutic target identification and validation.Nucleic Acids Res2017
27899562The ChEMBL database in 2017.Nucleic Acids Res2017
27910877A comprehensive map of molecular drug targets.Nat Rev Drug Discov2017
27903890Pharos: Collating protein information to shed light on the druggable genome.Nucleic Acids Res2017
28356508The druggable genome and support for target identification and validation in drug development.Sci Transl Med2017
28602100Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery.Expert Opin Drug Discov2017
27910877A comprehensive map of molecular drug targets.Nat Rev Drug Discov2017
27903890Pharos: Collating protein information to shed light on the druggable genome.Nucleic Acids Res2017
27899665Open Targets: a platform for therapeutic target identification and validation.Nucleic Acids Res2017
27678076A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL.J Biomed Semantics2016
26582922SureChEMBL: a large-scale, chemically annotated patent document database.Nucleic Acids Res2016
27678076A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL.J Biomed Semantics2016
27774140Open PHACTS computational protocols for <i>in silico</i> target validation of cellular phenotypic screens: knowing the knowns.Medchemcomm2016
26582922SureChEMBL: a large-scale, chemically annotated patent document database.Nucleic Acids Res2016
27774140Open PHACTS computational protocols for <i>in silico</i> target validation of cellular phenotypic screens: knowing the knowns.Medchemcomm2016
25313161The complex portal--an encyclopaedia of macromolecular complexes.Nucleic Acids Res2015
25883136ChEMBL web services: streamlining access to drug discovery data and utilities.Nucleic Acids Res2015
25313161The complex portal--an encyclopaedia of macromolecular complexes.Nucleic Acids Res2015
25348214PPDMs-a resource for mapping small molecule bioactivities from ChEMBL to Pfam-A protein domains.Bioinformatics2015
  • 1 - 50 of 102

Recommended Authors

The University of New Mexico School of Medicine
Career Start Year 2016
Number of shared co-authors 5
Princess Margaret Cancer Centre, University Health Network, University Ave.
Career Start Year 2013
Number of shared co-authors 2
Hacettepe University
Career Start Year 2013
Number of shared co-authors 13
Jiangsu University
Career Start Year 2009
Number of shared co-authors 2
Institute for Neurodegenerative Diseases, University of California san francisco
Career Start Year 2007
Number of shared co-authors 5
National Center for Biotechnology Information, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 13
Department of Pharmaceutical Biosciences, Uppsala University
Career Start Year 2006
Number of shared co-authors 10
Washington University School of Medicine
Career Start Year 2005
Number of shared co-authors 2
St. Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 5
Maastricht University
Career Start Year 2003
Number of shared co-authors 20
Swedish Toxicology Sciences Research Center, Karolinska Institutet
Career Start Year 2002
Number of shared co-authors 5
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 2002
Number of shared co-authors 8
Inc. 16 Dekalb Pike
Career Start Year 2002
Number of shared co-authors 0
Hospital del Mar Medical Research Institute (IMIM), Universitat Pompeu Fabra
Career Start Year 2001
Number of shared co-authors 5
CSC - IT Center for Science Ltd
Career Start Year 1999
Number of shared co-authors 9
Broad Institute
Career Start Year 1999
Number of shared co-authors 6
INSERM
Career Start Year 1998
Number of shared co-authors 0
Institucio Catalana de Recerca i Estudis Avancats (ICREA)
Career Start Year 1997
Number of shared co-authors 10
Broad Institute
Career Start Year 1997
Number of shared co-authors 1
Universitat Tubingen, Institut fur Arbeitsmedizin
Career Start Year 1996
Number of shared co-authors 25
Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg
Career Start Year 1996
Number of shared co-authors 2
Takeda California Inc.
Career Start Year 1995
Number of shared co-authors 1
National Center for Advancing Translational Science, 9800 Medical Center Drive
Career Start Year 1993
Number of shared co-authors 6
Indiana University Bloomington
Career Start Year 1992
Number of shared co-authors 8
Institute for Physiology, Charite-University Medicine Berlin
Career Start Year 1990
Number of shared co-authors 3
Lilly Research Laboratories
Career Start Year 1989
Number of shared co-authors 2
Stanford University
Career Start Year 1982
Number of shared co-authors 5
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 3
Lilly Research Laboratories
Career Start Year 1977
Number of shared co-authors 2
National Center for Biotechnology Information
Career Start Year 1973
Number of shared co-authors 0

Collaborators

Institute of Cardiovascular Science, University College London
Co-authored papers 24
Co-authored papers 23
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 14
European Molecular Biology Laboratory - European Bioinformatics Institute
Co-authored papers 10
Co-authored papers 6
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 6
Expert Systems Inc.
Co-authored papers 5
Co-authored papers 4
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 4
University of New Mexico School of Medicine
Co-authored papers 4
Connected Discovery Ltd
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Co-authored papers 4
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Vertex Pharmaceuticals
Co-authored papers 3
Co-authored papers 3
European Bioinformatics Institute
Co-authored papers 3
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 3
Co-authored papers 3
EMBL's European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Institute for Data Science and Computing, University of Miami
Co-authored papers 3
Co-authored papers 3
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers 3